Locations:
Search IconSearch

Cancer

20496714399_9d12e253e1_z_650x450
February 4, 2019/Cancer/News & Insight

Electronic Brachytherapy: Is It a Viable Option?

Why experts advise against it for breast, skin and gynecologic cancers

18-RHE-10377-Calabrese-Hero-Image-650x450pxl
January 22, 2019/Cancer

A Novel Tumor Board for Patients with Immune-Related Adverse Events

Collaborating to treat this emerging complication of CPI

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

nci-vol-9189-150_650x450

Gene Profile Test Holds Predictive Potential for Early Stage Melanoma Patients

Test helpful for SLN-negative, stage I to IIA and thin tumors

19-LRI-043_CQD_Eng-PTEN-variant_650x450

FDA Recognizes PTEN Variant Criteria

Earlier detection of certain cancers a likely result

19-LRI-044_Cheng-personal-mutanomes_CQD_650x450

Personal Mutanomes, Precision Oncology and Drug Discovery

Toward detailed, personalized maps of identified and interpreted genomic variation

amyloid_650x450
January 15, 2019/Cancer/Research

New Chemotherapy Regimen Proves Effective in Treating Amyloidosis

Refractory patients respond to combination therapy

Researchers in lab

New Grants Boost Hereditary Breast and Ovarian Cancer Research

Understanding resistance in PARP inhibitor therapy

BackPage 69 of 86Next

Advertisement

Ad